!Moderna stock jumps over 85% as cancer vaccine trial boosts investor confidence

shares made a considerable jump on Wednesday after the company and Merck announced positive results from their personalised mRNA cancer treatment. The stock went up more than 110% in early trading, putting it on track for its biggest-ever one-day gain. The trial marks a major milestone for Moderna as it looks to expand its business in India. It is also being seen as a breakthrough for mRNA technology, with the study marking the first successful Phase 3 trial of an mRNA-based cancer therapy. ‘For 3-5 years of investment